Please login to the form below

Not currently logged in
Email:
Password:

Braeburn Pharmaceuticals

This page shows the latest Braeburn Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

FDA gives green light for opioid addiction implant

FDA gives green light for opioid addiction implant

Titan and Braeburn's Probuphine is first implant of its kind to win US approval. ... The first implant treatment for opioid dependence will be launched in the US shortly following FDA approval for Titan Pharma and Braeburn Pharma's Probuphine.

Latest news

  • FDA panel backs approval of first opioid addiction implant FDA panel backs approval of first opioid addiction implant

    An FDA panel has backed approval of a long-acting buprenorphine implant for the management of opioid addiction developed by Titan Pharma and partner Braeburn Pharma. ... At the committee meeting, Braeburn presented summary safety findings with a

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Investing in our People
As a small, boutique agency we can and do invest heavily in our team, who produce amazing results for our clients....
Body image and mental health: The psoriasis connection
As part of mental health awareness week, the Mental Health Foundation (MHF) have released a new report on the interaction between body image and mental health. Our Medical Writer Alex...
It’s not the end of the world, is it?
Industry change isn’t always gradual – it can be apocalyptic...

Infographics